NCT05244694View on ClinicalTrials.gov

Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
VasoconstrictionHealthyInsulin Resistance
Interventions
DRUG

Insulin

Priming dose then a constant infusion at 40 mU•m-2•min-1

Trial Locations (1)

65211

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT05244694 - Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction | Biotech Hunter | Biotech Hunter